A Telephone Feedback System for Prevention of Chronic Pain Relapse

NCT ID: NCT00266773

Last Updated: 2013-02-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

158 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-11-30

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether a telephone-based self-monitoring and skills review program with personalized therapist feedback following group CST for chronic pain can reduce and prevent relapse of the pain, physical disability, and psychological distress experienced by patients with chronic pain of the muscles and bone.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

IVR (Interactive Voice Response) is a computer-based, automated telephone system that enables callers to respond to a recorded voice via the telephone keypad. Using this technology, therapeutic IVR (TIVR) was developed as a tool for providing maintenance treatment following group cognitive-behavioral coping skills training (CST), a widely-used behavioral treatment for chronic pain. TIVR has four components:

* an automated daily questionnaire for self-monitoring
* a review of coping skills
* guided behavioral rehearsals of CST coping skills
* personalized monthly feedback messages recorded onto TIVR by the therapist

All four components can be accessed remotely by patients via any touch-tone phone. In a small pilot study, people with severe, chronic musculoskeletal pain received 11 weeks of either CST alone or CST with TIVR access and therapist feedback. Those who used TIVR had better pain outcomes than those who did not. This study will compare the effectiveness of TIVR with or without therapist feedback to a control group not using TIVR at all.

To be eligible for this study, participants must have just completed an 11-week course of CST through the University of Vermont College of Medicine's MindBody Medicine Clinic. At study entry, participants will be randomly assigned to one of three groups. Group 1 is a control group that will not receive any intervention through this study. Group 2 participants will receive full access to TIVR and will get a minimal monthly message from their therapist, who will not use the participant's daily questionnaire data. Group 3 participants will receive full access to TIVR and will get personalized monthly messages from their therapist based on the participant's daily questionnaire data. Messages for participants will include any trends the therapist has noted in a participant's stress, sleep, mood, pain levels, coping, and activity, as reported through TIVR. All study participants may continue to receive treatment from their regular physician or take part in other pain management techniques during this study, but such treatment will not be provided through this study.

Upon completing the 11 weeks of CST, all participants will be asked to complete a packet of questionnaires about their chronic pain. At the start of this study, participants in Groups 2 and 3 will have a 30-minute training session on how to use and access TIVR. At Months 4, 8, and 12, participants from all three groups will have follow-up interviews and will complete additional questionnaires.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pain and Relapse Prevention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Control - standard care only

Group Type NO_INTERVENTION

No interventions assigned to this group

2

Attention Control - standard care plus 6 months TIVR receiving minimal monthly feedback

Group Type EXPERIMENTAL

Chronic pain therapeutic interactive voice response (TIVR) system

Intervention Type BEHAVIORAL

Therapeutic Interactive Voice Response as a daily self monitoring and relapse prevention tool with didactic reviews and practices of recorded skills and monthly feedback based on daily calls

3

Standard care plus 6 months TIVR receiving detailed monthly feedback

Group Type EXPERIMENTAL

Chronic pain therapeutic interactive voice response (TIVR) system

Intervention Type BEHAVIORAL

Therapeutic Interactive Voice Response as a daily self monitoring and relapse prevention tool with didactic reviews and practices of recorded skills and monthly feedback based on daily calls

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chronic pain therapeutic interactive voice response (TIVR) system

Therapeutic Interactive Voice Response as a daily self monitoring and relapse prevention tool with didactic reviews and practices of recorded skills and monthly feedback based on daily calls

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Completed 11 weeks of CST through the University of Vermont College of Medicine - Health Behavior Research Center prior to study entry
* At least 6 months of musculoskeletal pain caused by back, neck, or shoulder pain; osteoarthritis; or fibromyalgia
* Meet study threshold for pain severity with a Typical Pain score of 4 or more on a 10-point scale adapted from the McGill Pain Questionnaire (80)
* Receiving ongoing standard pain management from a physician (typically involving oral analgesic medication and physical therapy, with or without anesthetic or steroid injections)

Exclusion Criteria

* Unable to perform usual self care
* Cancer that causes or influences patient's chronic pain
* Cancer requiring radiation or chemotherapy or metastatic cancer of any type
* Reflex sympathetic dystrophy (RSD)
* Neuropathic pain
* Awaiting a pain-related surgical procedure
* Involved in pain-related litigation or awaiting disability determination
* Behavioral problems or psychotic disorders that may interfere with the study
* Inability to use telephone-based TIVR due to cognitive or hearing impairment
* At risk for suicide
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

Sponsor Role collaborator

University of Vermont Medical Center

OTHER

Sponsor Role collaborator

University of Vermont

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Magdalena Naylor, MD, PhD

Magdalena R. Naylor, MD, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Magdalena R. Naylor, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Vermont College of Medicine - MindBody Medicine Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Vermont College of Medicine - MindBody Medicine Clinic

Burlington, Vermont, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Keefe FJ, Rumble ME, Scipio CD, Giordano LA, Perri LM. Psychological aspects of persistent pain: current state of the science. J Pain. 2004 May;5(4):195-211. doi: 10.1016/j.jpain.2004.02.576.

Reference Type BACKGROUND
PMID: 15162342 (View on PubMed)

Naylor MR, Helzer JE, Naud S, Keefe FJ. Automated telephone as an adjunct for the treatment of chronic pain: a pilot study. J Pain. 2002 Dec;3(6):429-38. doi: 10.1054/jpai.2002.129563.

Reference Type BACKGROUND
PMID: 14622728 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.med.uvm.edu/mbmc

Click here for the University of Vermont College of Medicine - MindBody Medicine Clinic Web site

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01AR052131

Identifier Type: NIH

Identifier Source: secondary_id

View Link

5R01AR052131

Identifier Type: NIH

Identifier Source: secondary_id

View Link

R01AR052131

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.